Tuberculosis, Leprosy and Buruli Ulcer are diseases of public health importance in Nigeria, affecting thousands of Nigeria with high level or morbidity, disability and mortality among those affected. Nigeria has the highest burden of TB in Africa and is also among the few countries that are still notifying above 1,000 cases of Leprosy annually.

The country in 2023 recorded the highest TB notification ever since the establishment of the NTBLCP in 1989. A total of 371,019 TB cases was notified in 2023, this represents more than 100% achievement of the target set for TB case finding and notification for the year 2023 in the National strategic plan. The country recorded a high treatment success rate of 93% in 2023.

Tuberculosis, Leprosy and Buruli Ulcer are diseases of public health importance in Nigeria, affecting thousands of Nigeria with high level or morbidity, disability and mortality among those affected. Nigeria has the highest burden of TB in Africa and is also among the few countries that are still notifying above 1,000 cases of Leprosy annually.

The country in 2022 recorded the highest TB notification ever since the establishment of the NTBLCP in 1989. A total of 285,561 TB cases was notified in 2022, this represents more than 100% achievement of the target set for TB case finding and notification for the year 2022 in the National strategic plan. The country recorded a high treatment success rate of 89% in 2022.

Nigeria with an estimated population of over 192 million people in 2018 and TB incidence rate of 219/100,000, ranks 6th among 30 high TB burden countries of the world. The National

Tuberculosis, Leprosy and Buruli ulcer Control Programme (NTBLCP) has continued to make progress in the control of TB, Leprosy and Buruli Ulcer in Nigeria annually. The NTBLCP in line with the national health strategic plan commenced implementation of the revised National Strategic Plan for Tuberculosis Control 2016 – 2020 and revised the National Strategic plan for Leprosy and Buruli Ulcer control 2016 – 2020 with the aim to reduce the prevalence of TB, Leprosy and Buruli Ulcer to levels where they no longer constitute public health concern in the country.

In 2018 NTBLCP rolled out strategic interventions such as Active case finding, Free chest X-ray for child TB cases and OPD screening in 10 states.

The laboratory network includes 419 (405 plus 14 installed in 2021) installed GeneXpert machines, 3398 microscopy centers and 10 TB culture/LPA laboratories. These laboratories are in the primary, secondary and tertiary level of implementation depending on the type of tests. However, the primary tools are majorly conducted at all levels of implementation. A total of 11 TB-LAMP platform was installed across 7 states (Anambra, Nasarawa, Kano, Rivers, Cross Rivers, Katsina, and Taraba) in 2021. There is additional 1 PPM facility in FCT supporting the FCT TBL with TB Lamp (Epiconsult diagnostics). There is an expected expansion of 25 TB- LAMP machines in 2022.

The 2019 annual report was therefore developed to track the progress made towards achieving the UNHLM targets while documenting key successes, challenges and lessons learnt. The annual report also highlight some priority area of focus for the programme in 2020 based on the lessons learnt in 2019.

The 2020 annual report of the NTBLCP has been developed to highlight the progress made in accelerating TB case finding in Nigeria despite the COVID-19 pandemic, provide comprehensive report on programme performance in the efforts towards controlling TB, Leprosy and BU diseases in Nigeria. It gives detailed analysis on progress made at state and LGA level and identifies key challenges to programme implementation and priority area of focus in 2018 towards ending TB epidemic in Nigeria.

The aim of the rapid advice is to provide updated guidance on diagnosis and treatment of child and adolescent TB to healthcare workers (HCWs) at all levels to improve access to child TB diagnosis and treatment.

The 2021 National Strategic Framework for TB/HIV collaborative activities is a five-chapter document that serves as a policy guide for the implementation of TB/HIV collaborative activities in Nigeria. It highlights the desired structure and mechanisms for effective collaboration between the two programs

TB and HIV constitute major public health problems in Nigeria. The burden of these diseases is further compounded by the impact they have on each other; HIV fuels the burden of TB while TB on the other hand is the commonest infection among People Living with HIV (PLHIV). The interaction between these two diseases increases the morbidity and mortality among TB/HIV co- infected patients and also stretches the already challenged infrastructure of the health sector.

WHAT YOU NEED TO KNOW!